Researchers say that cannabis-based medications could slow down or prevent the onset of Alzheimer’s disease. In experiments, this type of medicine triggered the formation of new brain cells and cut inflammation linked to dementia. Read more… continue reading...
TORONTO, ONTARIO, MEDIA ADVISORY–(Marketwire - Feb. 13, 2008) - Sunnybrook researchers are the first to provide evidence of the harmful effects of inhaled cannabis on the cognitive and mental health of patients with multiple sclerosis (MS).
“Patients with MS who regularly smoke cannabis are shown to have more extensive cognitive abnormalities, such as difficulties in processing information and short-term verbal memory, and greater lifetime psychopathology than those who do not use cannabis,” says Dr. Anthony Feinstein, study author and neuropsychiatrist at Sunnybrook Health Sciences Centre. continue reading...
PASADENA, CA–(Marketwire - August 22, 2007) - Vision Media’s recent life and health related article by Alice Abler entitled, “Marijuana: Docile Drug or Wicked Weed?” addresses the fact that marijuana, also known as Cannabis sativa, may not be the docile drug it was once thought to be. Used for both medicinal and recreational purposes for thousands of years, recent research points towards the fact that whether we smoke, ingest, inhale or take it subcutaneously, if the effects of recreational cannabis use don’t kill you, they could truly blow your mind.
According to the National Institute of Drug Abuse lifetime marijuana abuse decreased among 10th-graders, from 34.1 percent in 2005 to 31.8 percent in 2006. Past year prevalence of marijuana abuse fell by 36 percent among 8th-graders since their peak year of abuse (1996) and by 28 percent among 10th-graders and 18 percent among 12th-graders since their peak year of abuse (1997). continue reading...
